Tue, May 31, 2016
India's Sun Pharmaceutical Industries issued a weaker-than-expected annual sales outlook as it grapples with increased competition in the United States (US) as well as supply constraints, sending its shares 5% lower.
More >
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.